potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide

C72H80BBrCl2F3K3N21O11P — CID 159747939

About potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide

potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide (PubChem CID 159747939) has the molecular formula C72H80BBrCl2F3K3N21O11P and a molecular weight of 1782.45 g/mol. Its IUPAC name is potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide.

Molecular Properties

• Compound Name: potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide
• PubChem CID: 159747939
• Molecular Formula: C72H80BBrCl2F3K3N21O11P
• Molecular Weight: 1782.45 g/mol
• Exact Mass: 1779.36
• IUPAC Name: potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide
• SMILES: CC(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3N3CCOCC3)ccc2n1.CC(=O)Nc1cn2nc(B3OC(C)(C)C(C)(C)O3)ccc2n1.CC(Cl)Cl.Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(N)cn3n2)c1N1CCOCC1.Cn1nc(-c2ccc(F)cc2)c(Br)c1N1CCOCC1.O=[P+]([O-])O[O-].[K+].[K][K]
• InChI: InChI=1S/C22H22FN7O2.C20H20FN7O.C14H19BN4O3.C14H15BrFN3O.C2H4Cl2.3K.HO4P/c1-14(31)24-18-13-30-19(25-18)8-7-17(26-30)20-21(15-3-5-16(23)6-4-15)27-28(2)22(20)29-9-11-32-12-10-29;1-26-20(27-8-10-29-11-9-27)18(19(25-26)13-2-4-14(21)5-3-13)15-6-7-17-23-16(22)12-28(17)24-15;1-9(20)16-11-8-19-12(17-11)7-6-10(18-19)15-21-13(2,3)14(4,5)22-15;1-18-14(19-6-8-20-9-7-19)12(15)13(17-18)10-2-4-11(16)5-3-10;1-2(3)4;;;;1-4-5(2)3/h3-8,13H,9-12H2,1-2H3,(H,24,31);2-7,12H,8-11,22H2,1H3;6-8H,1-5H3,(H,16,20);2-5H,6-9H2,1H3;2H,1H3;;;;1H/q;;;;;;;+1;/p-1
• InChIKey: NDHBYBFZVVWYOG-UHFFFAOYSA-M
• XLogP: 5.25
• TPSA: 356.54 Ų
• H-Bond Donors: 3
• H-Bond Acceptors: 30
• Rotatable Bonds: 12
• Heavy Atoms: 115
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1782.45
LogP ≤ 5	5.25
H-Bond Donors ≤ 5	3
H-Bond Acceptors ≤ 10	30

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide?

The IUPAC name of potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide (CID 159747939) is potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide.

What is the SMILES notation for potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide?

The canonical SMILES for potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide is CC(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3N3CCOCC3)ccc2n1.CC(=O)Nc1cn2nc(B3OC(C)(C)C(C)(C)O3)ccc2n1.CC(Cl)Cl.Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(N)cn3n2)c1N1CCOCC1.Cn1nc(-c2ccc(F)cc2)c(Br)c1N1CCOCC1.O=[P+]([O-])O[O-].[K+].[K][K].

What is the InChIKey of potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide?

The InChIKey is NDHBYBFZVVWYOG-UHFFFAOYSA-M. The full InChI is InChI=1S/C22H22FN7O2.C20H20FN7O.C14H19BN4O3.C14H15BrFN3O.C2H4Cl2.3K.HO4P/c1-14(31)24-18-13-30-19(25-18)8-7-17(26-30)20-21(15-3-5-16(23)6-4-15)27-28(2)22(20)29-9-11-32-12-10-29;1-26-20(27-8-10-29-11-9-27)18(19(25-26)13-2-4-14(21)5-3-13)15-6-7-17-23-16(22)12-28(17)24-15;1-9(20)16-11-8-19-12(17-11)7-6-10(18-19)15-21-13(2,3)14(4,5)22-15;1-18-14(19-6-8-20-9-7-19)12(15)13(17-18)10-2-4-11(16)5-3-10;1-2(3)4;;;;1-4-5(2)3/h3-8,13H,9-12H2,1-2H3,(H,24,31);2-7,12H,8-11,22H2,1H3;6-8H,1-5H3,(H,16,20);2-5H,6-9H2,1H3;2H,1H3;;;;1H/q;;;;;;;+1;/p-1.

What are the key properties of potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide?

potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide has a molecular weight of 1782.45 g/mol, XLogP of 5.25, 12 rotatable bonds, 3 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for potassium;4-[4-bromo-3-(4-fluorophenyl)-1-methylpyrazol-5-yl]morpholine;1,1-dichloroethane;6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-amine;N-[6-[3-(4-fluorophenyl)-1-methyl-5-morpholin-4-ylpyrazol-4-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide;oxido-oxidooxy-oxophosphanium;potassiopotassium;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide is sourced from PubChem (CID 159747939), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).